Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04029688
Title A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in the Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | NLD | GBR | FRA | ESP | CAN

Facility Status City State Zip Country Details
Arkansas Children's Hospital Research Institute Little Rock Arkansas 72202 United States Details
Lucile Packard Children's Hospital at Stanford University; Thoracic Oncology Palo Alto California 94304 United States Details
Arnold Palmer Hosp-Children Orlando Florida 32806 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Texas Health Science Center at San Antonio San Antonio Texas 78229 United States Details
Alberta Children'S Hospital Calgary Alberta T3B 6A8 Canada Details
Centre Leon Berard Lyon CEDEX 08 69373 France Details
Institut Curie Paris 75005 France Details
Gustave Roussy Villejuif 94805 France Details
Prinses Maxima Centrum Utrecht 3584 CS Netherlands Details
Hospital Sant Joan De Deu Esplugues De Llobregas Barcelona 08950 Spain Details
Hospital Infantil Universitario Nino Jesus Madrid 28009 Spain Details
Birmingham Children's Hospital Birmingham B4 6NH United Kingdom Details
The Royal Victoria Infirmary; Paediatric and Adolescent Oncology Unit Newcastle Upon Tyne NE1 4LP United Kingdom Details
Royal Marsden Hospital; Pediatric Unit Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field